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Abstract
Exposure to sustained hypoxia of 8 h duration increases the sensitivity of the
pulmonary vasculature to acute hypoxia, but it is not known whether exposure
to sustained hyperoxia affects human pulmonary vascular control. We hypoth-
esized that exposure to 8 h of hyperoxia would diminish the hypoxic pul-
monary vasoconstriction (HPV) that occurs in response to a brief exposure to
hypoxia. Eleven healthy volunteers were studied in a crossover protocol with
randomization of order. Each volunteer was exposed to acute isocapnic
hypoxia (end-tidal PO2 = 50 mmHg for 10 min) before and after 8 h of hyper-
oxia (end-tidal PO2 = 420 mmHg) or euoxia (end-tidal PO2 = 100 mmHg).
After at least 3 days, each volunteer returned and was exposed to the other
condition. Systolic pulmonary artery pressure (an index of HPV) and cardiac
output were measured, using Doppler echocardiography. Eight hours of hyper-
oxia had no effect on HPV or the response of cardiac output to acute hypoxia.
Introduction
The human pulmonary circulation responds to alveolar
hypoxia with an abrupt acute vasoconstriction occurring
over a few (~5) minutes. If the hypoxia is maintained,
this constriction begins to intensify after about 40 min
(Talbot et al. 2005), and continues to increase over the
periods of 2–8 h that have been studied in various labora-
tory protocols (Dorrington et al. 1997; Balanos et al.
2002; Talbot et al. 2014). This increasing vasoconstriction
in the presence of a constant sustained hypoxic stimulus
can be thought of as ‘pulmonary vascular acclimatization’
to hypoxia by analogy with the human ventilatory
acclimatization to hypoxia that follows a similar time
course. The term ‘hypoxic pulmonary vasoconstriction’
(HPV) is variably applied to both the acute and the
longer term responses.
The question of whether the oxygen sensing of the pul-
monary vasculature and that of the ventilatory control
system share similarities in the manner in which they
generate their respective acclimatizations to hypoxia con-
tinues to receive attention. This is of particular interest
given the observation that both pulmonary vascular and
ventilatory sensitivities to hypoxia are modulated by the
hypoxia-inducible factor (HIF) system of transcription
regulation (Smith et al. 2006). In a recent study of 80
volunteers, each exposed to 8 h of isocapnic hypoxia
(end-tidal PO2 , PETO2 = 55 mmHg), the time courses of
these two processes of acclimatization were found to be
very similar, and the magnitudes of the acclimatization
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responses seen at 8 h represented more than a doubling
of the early responses seen at 30 min of hypoxia (Fate-
mian et al. 2015). However, on assessing the variability
between individuals with regard to the two responses, an
absence of correlation was found. Indeed, a fundamental
difference between the two processes of acclimatization
was revealed by that study: the increase in sensitivity of
the pulmonary vascular response to acute hypoxic chal-
lenges during the acclimatization was independent of the
starting sensitivity on first exposure, whereas the increase
in sensitivity of the ventilatory response to acute hypoxic
challenges during the acclimatization was in proportion
to the starting sensitivity on first exposure. This difference
remains unexplained, and highlights our lack of a com-
plete understanding of the underlying cellular pathways.
A feature of the pulmonary vascular and the ventilatory
responses to oxygen that is of related interest is the extent
to which ‘desensitization’ can be induced in both systems
during a prolonged exposure to a high level of oxygen,
namely to sustained hyperoxia. In 14 volunteers exposed
to 8 h of isocapnic hyperoxia (PETO2 = 300 mmHg), Ren
and colleagues found a progressive decrease in ventilation
over 8 h (after an initial anticipated (Becker et al. 1996)
hyperventilatory response to hyperoxia), and a significant
decrease of 16% in the sensitivity of the ventilatory
response to brief periods of hypoxia during the 8-h expo-
sure (Ren et al. 2000). A similar phenomenon was shown
during a 5-day exposure to very modest hyperoxia
(PETO2 = normal value + 10 mmHg) (Donoghue et al.
2005). The human pulmonary circulation has recently
been shown to respond to acute hyperoxia (PETO2 = 100–
175 mmHg) with a modest dilatation (Croft et al. 2013),
but it is not known whether sustained hyperoxia is cap-
able of inducing a progressive decrease in response, a
desensitization analogous to that seen in the ventilatory
control system. We hypothesized that exposure to 8 h of
isocapnic hyperoxia would diminish the HPV that occurs
in response to a brief (acute) exposure to hypoxia,
thereby mirroring the increase in acute HPV that is
brought about by prior exposure to 8 h of hypoxia.
Methods
Participants
Eleven healthy volunteers (10 men, one woman) were
recruited to this study with a mean age of 22.5 years
(SD = 3.4) and with a range of 18–27 years. Mean height
and weight were 176.9 cm (SD = 5.4) and 67.9 kg
(SD = 11.0). No volunteer had a history of respiratory,
cardiac, or other diseases. All volunteers visited the labo-
ratory in advance of participation to confirm detectability
of tricuspid regurgitation with echocardiography and
discuss the experiment requirements and details. On each
experiment day, participants were requested to refrain
from alcohol and drinks containing caffeine. The female
participant underwent the experiment within the first
14 days of her menstrual cycle. Experiment information
sheets were given in advance and written informed con-
sent was obtained from each volunteer before participa-
tion. This study was approved by East Central London
Research Ethics Committee 1 (Reference: 10/H0721/21)
and was performed in accordance with the general ethical
principles of the Declaration of Helsinki.
Protocols
Figure 1 is a schematic of the time course for the proto-
col. Each participant underwent two different 8-h expo-
sures in a customized chamber: (1) isocapnic hyperoxia,
with PETO2 held at 420 mmHg and end-tidal PCO2
(PETCO2 ) held at each volunteer’s pre-exposure value; and
(2) isocapnic euoxia (control), in which the volunteer’s
PETO2 was held at 100 mmHg and PETCO2 was held at each
volunteer’s pre-exposure value. The sequence of exposures
was randomized and concealed from each volunteer. At
least 3 days separated each individual’s two exposures to
minimize any potential interactions. The technique for
such 8-h exposures to hyperoxia and control (euoxia) has
been described previously (Ren et al. 2000). In short, vol-
unteers wore a nasal catheter through which respired gas
was constantly sampled, and inspired, and end-tidal PO2
and PCO2 were identified by computer on a breath-by-
breath basis. The composition of chamber (inspired) gas
was adjusted automatically every 5 min, or at manually
overridden intervals, to bring the end-tidal gases as close
as possible to the target values.
Measurements made before, during & after
the 8-h chamber exposures
The effects of sustained exposure were examined by mea-
surements during the exposure itself and by acute hypoxic
challenges before and after the exposure. During the
45 min before, and within 35 min following, each 8-h
exposure, the volunteer experienced an acute hypoxic
challenge with three gas-controlling steps: (1) isocapnic
euoxia, with PETO2 held at 100 mmHg and PETCO2 held at
the volunteer’s pre-exposure value for 10 min; (2) isocap-
nic hypoxia, with PETO2 held at 50 mmHg and PETCO2
held at the volunteer’s pre-exposure value for 10 min; (3)
isocapnic euoxia, with PETO2 and PETCO2 held as step 1 for
5 min. During the break of up to 10 min between leaving
the chamber and starting the three gas-controlling steps,
the volunteer breathed room air. Our experience from
previous studies has been that changes in pulmonary
2017 | Vol. 5 | Iss. 17 | e13396
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vascular sensitivity following an 8-h exposure to hypoxia
persist for one or more hours after finishing the exposure.
For example, a study with pulmonary artery catheters
found a persistent increase in sensitivity of the pulmonary
vasculature to acute hypoxia present 3 h after a chamber
exposure to 8 h of hypoxia (Dorrington et al. 1997). We
therefore assumed that if a desensitization was produced
by the 8-h period of hyperoxia, it would not be ‘washed–
out’ within that 20-min period.
The technique for these acute exposures to 10-min
periods of hypoxia has been described previously (Rob-
bins et al. 1982; Liu et al. 2013). In short, volunteers
wore a nose clip and breathed through a mouthpiece,
from which a catheter provided constant sampling of
respired gas, and within which a turbine provided mea-
surement of ventilation. Identification of inspired and
end-tidal PO2 and PCO2 breath-by-breath was used to
adjust the inspired gas automatically to bring the end
tidal gases as close as possible to the target values.
Throughout the acute hypoxic exposures, each volun-
teer lay in the left lateral recumbent position as they
breathed through a mouthpiece. During the hourly mea-
surements in the chamber, each volunteer lay in the same
left lateral recumbent position while breathing chamber
gas. Systolic pulmonary artery pressure (SPAP), heart
rate, stroke volume, and cardiac output were measured at
minute intervals during the acute hypoxic challenges, and
at hourly intervals during the 8-h chamber exposures,
using established echocardiographic techniques and
equipment (Vivid i with 3S-RS transducer, GE Health-
care; Vivid q with M4S-RS transducer, GE Healthcare)
(Smith et al. 2008). In short, SPAP is estimated from the
pressure difference between the right ventricle and the
right atrium (estimated using Bernoulli’s equation from
the peak velocity of a systolic tricuspid regurgitant jet
obtained using continuous-wave Doppler), to which was
added an estimated right atrial pressure of 5 mmHg. The
measurements obtained at time zero were called ‘pre-
exposure values’.
During both chamber exposures and acute hypoxic
challenges, peripheral oxyhemoglobin saturation (SpO2)
was measured, using a pulse oximeter (Ohmeda Biox
3740 Pulse Oximeter, BOC Healthcare) and a finger
probe (OXY-F4-H Finger Sensor, GE Healthcare). The
Ohmeda Biox 3740 uses two wavelengths for its detection
of the pulsatile component of tissue/blood transmission:
660 nm (red) and 940 nm (infrared). The manufacturer
states that carboxyhemoglobin may erroneously increase
readings and that the increase is expected to be approxi-
mately equal to the amount of carboxyhemoglobin pre-
sent. The manufacturer also states that methemoglobin
tends to drive the reading toward 85%. Motion artifact
would be a potential problem with this device, but we
ensured volunteers remained very still during measure-
ments. Heart rate was measured through a three-lead
electrocardiogram (Micromon 7142 B ECG, Kontron
Medical).
Ventilation was measured during the acute hypoxic
challenges by a turbine device (Ventilation Measurement
Module, SensorMedics). All equipment was calibrated
before each experiment.
Statistical analyses
ANOVA was used to test for differences between the two
8-h protocols. The Bonferroni procedure was used in the
multiple comparisons (post hoc analysis) with variables
during acute hypoxic challenges before and after the 8-h
exposures. The statistical significance level was set at 0.05.
Values are mean  SEM if not otherwise stated. The
analysis was performed in IBM SPSS software package
version 20.
Results
All of the 11 volunteers completed the study, and none
reported significant discomfort from the chamber expo-
sures or acute hypoxic exposures.
Changes during the 8-h exposures to euoxia
& hyperoxia
Gas control during the chamber exposures is shown in
Figure 2. In the hyperoxia protocol, volunteers’ PETO2 was
Figure 1. Schematic diagram of time-course of the two protocols. IE, isocapnic euoxia; IH, isocapnic hypoxia. This was a cross-over study, in
which each volunteer experienced two conditions (hyperoxia and euoxia) on separate occasions.
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increased to approximately 420 mmHg after 1.5 h in the
chamber.
In the euoxia (control) protocol, volunteers’ PETO2 was
maintained at 100 mmHg during 8 h in the chamber. In
both protocols, the PETCO2 of each volunteer remained
fairly constant during 8 h; there was a slight fluctuation
during sustained hyperoxia.
Cardiopulmonary responses to sustained hyperoxia are
plotted in Figure 3. There was a significant difference
between the hyperoxia exposure and the euoxia exposure
in the values of SpO2 (Hyperoxia: 98.1  0.4%; Control:
96.8  0.3%, P = 0.016) (Fig. 3E). It should be noted
that SpO2 was measured with volunteers in the left lateral
recumbent position required for the simultaneous mea-
surement of SPAP. It may well be that this posture con-
tributes to the generation of a degree of dependent
atelectasis that lowers the SpO2 to mean values somewhat
below 100% during the breathing of approximately 60%
oxygen. No significant differences were found in SPAP,
cardiac output, stroke volume, or heart rate between the
two conditions (Fig. 3A–D).
Changes occurring during the acute hypoxic
challenges before and after 8-h exposures
Gas control during the acute hypoxic challenges prior to
and postchamber exposures is shown in Figure 4. PETO2
and PETCO2 remained stable during acute hypoxic chal-
lenges. Cardiopulmonary responses during acute hypoxic
challenges prior to and postchamber exposures are shown
in Figure 5. The SPAP values during acute hypoxic
challenges prior to and post-8-hour exposures are simi-
lar in both exposures (Fig. 5A). No differences were
found between the hyperoxia and control protocols with
regard to cardiac output, stroke volume, or heart rate
(Fig. 5B–D).
After the 8-h hyperoxic exposure, SpO2 during isocap-
nic euoxia was higher than before the exposure (hyper-
oxia prior: 97.9  0.3%; hyperoxia post: 98.9  0.3%,
P = 0.045) (Fig. 5E). No equivalent significant difference
was found in the control protocol. Although ventilation
after the 8-h hyperoxia exposures was higher than ventila-
tion before the exposure, the difference was not statisti-
cally significant (Fig. 5F). We note that a slightly lower
SpO2 during acute hypoxia following the 8 h of hyperoxia
may suggest an increase in the mismatch between perfu-
sion and ventilation. If this were the case, one might
expect a lower SpO2 during the euoxic phase of these
tests; interestingly the opposite was found to be the case,
with the SpO2 being significantly higher.
Discussion
The main finding of this study is the absence of any pul-
monary vascular desensitization to hypoxia during an
exposure to isocapnic hyperoxia lasting 8 h. We had
hypothesized, drawing parallels with ventilatory acclimati-
zation to hypoxia and desensitization to hyperoxia, that
exposure to 8 h of hyperoxia would diminish the HPV
that occurs in response to a brief exposure to hypoxia. In
Figure 5A, it can be seen that no difference in the acute
response of SPAP to 10 min of isocapnic hypoxia was
detectable following the 8-h hyperoxic exposure, when
compared with control experiments. Furthermore, the
absence of any effect of 8 h of hyperoxia on the response
of cardiac output to acute hypoxia helps to ensure that
no subtle pulmonary vascular effect of the hyperoxia is
masked by some difference in flow through the pul-
monary vascular system in the experiments shown in Fig-
ure 5.
A related indication that no change in the acute HPV
response to changes in PETO2 developed during the 8-h
Figure 2. Control of end-tidal and inspired gases in chamber. PCO2 , partial pressure of carbon dioxide, PO2 , partial pressure of oxygen. (A) Gas
control of inspired PCO2 , PICO2 (circles) and expired PCO2 , PETCO2 (triangles); (B) Control of inspired PO2 , PIO2 (circles) and expired PO2 , PETO2
(triangles). Data from hyperoxia and euoxia protocols are shown as filled and empty symbols, respectively. Values are means  SEM.
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hyperoxic exposure is that SPAP itself did not differ from
the euoxic control during the 8 h of hyperoxia, in con-
trast to the gradual rise in SPAP measured during an 8-h
exposure to isocapnic hypoxia (Talbot et al. 2014; Fate-
mian et al. 2015).
Limitations in the study
This study was not designed to resolve a ventilatory
desensitization of the kind observed by Ren et al. (2000)
who studied volunteers exposed to 8 h of eucapnic hyper-
oxia at the level of PETO2 = 300 mmHg. In that study,
acute ventilatory sensitivity to eucapnic hypoxia was mea-
sured, using sequences of six 1-min exposures to hypoxia,
from which dynamic modeling detected a fall in sensitiv-
ity Gp of 16% following the 8-h exposure to hyperoxia.
In the present study, a 10-min exposure to acute hypoxia
was used to study the acute pulmonary vascular response,
during which measurements of ventilation showed no sig-
nificant difference from control or baseline (Fig. 5F).
Figure 3. Cardiopulmonary responses during chamber exposures. (A) Systolic pulmonary artery pressure (SPAP); (B) Cardiac output; (C) Stroke
volume; (D) Heart rate; (E) Oxyhemoglobin saturation (SpO2) were measured pre-exposure (0-h) and at hourly intervals in hyperoxia (filled
circles) and euoxia (control, empty circles) exposures. Values are means  SEM. *P < 0.05 when comparing protocols.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Notwithstanding the difference between the techniques
used, the explanation for this difference between the find-
ings of the two studies is unclear. One possibility is that
the significantly higher peripheral oxyhemoglobin satura-
tion during the euoxic 10-min run into the acute hypoxic
exposure (Fig. 5E) may have been associated with a
greater excursion in the arterial PO2 seen by the chemore-
flex afferents in the carotid body and masked an effect
detected in the earlier study, using different methodology.
These observations suggest that it might be of benefit, in
studies of this kind, to be able to sample arterial blood
from an indwelling systemic arterial cannula in order to
be able to assess the extent to which manipulation of
PETO2 achieves similar values of arterial PO2 .
Comparison with acute effects of hyperoxia
in a previous study
A small nonsignificant difference in SPAP between the
euoxia and hyperoxia protocols of ~1 mmHg can be seen
in Figure 3A during the 8-h periods of chamber exposure.
During the exposure, there was a significant difference in
of SpO2 observed of 1.3%. The question arises as to
whether these findings are consistent with those seen in
an earlier study of the acute effects of isocapnic hyperoxia
on the human pulmonary circulation in exposures lasting
4–10 min (Croft et al. 2013). In that study, the sensitivity
of SPAP to changes in SpO2 was found to be
0.43  0.09 mmHg/% desaturation. For a difference in
SpO2 of 1.3%, this would predict an acute fall in SPAP of
0.56 mmHg, consistent with the observation made in the
current study of 8-h hyperoxia as being outside the
resolution available here. A new finding from the present
8-h exposures is that no observable gradual change in
SPAP is found to be induced by hyperoxia comparable to
the progressive elevation in SPAP observed between 1 and
8 h during isocapnic hypoxia in the same setting, using
the same methodology (Balanos et al. 2005; Talbot et al.
2014); in these studies, the degree of acclimatization was
commonly as great as, or greater than, the response
occurring within the first hour.
Cellular mechanisms of oxygen sensing
involving HIF
A body of evidence suggests that both pulmonary vascular
and ventilatory acclimatization to hypoxia are deter-
mined, at least in part, by the HIF regulators of transcrip-
tion (Smith et al. 2006), and that differences between the
two may be associated with different localizations or
other aspects of the components of this system. The pro-
cesses of pulmonary vascular and ventilatory acclimatiza-
tion are associated with an increase in the acute
sensitivities, respectively, of the pulmonary vasculature
and the ventilatory system to acute episodes of hypoxia.
Some studies have used these changes in acute sensitivi-
ties to assess the role of the HIF system. Thus, for exam-
ple, patients with Chuvash polycythemia have a
generalized upregulation of the HIF system, and display
both enhanced pulmonary vascular sensitivity and
enhanced ventilatory sensitivity to acute hypoxia, as well
as a dramatic degree of pulmonary arterial hypertension
during the 6 h of modest hypoxia associated with a long-
distance flight (Smith et al. 2006, 2013). Patients with a
gain-of-function mutation in HIF-2a show an enhanced
pulmonary vascular sensitivity to moderate acute hypoxia
in the presence of a normal ventilatory sensitivity to the
same stimulus (Formenti et al. 2011). In relation to a
Figure 4. Control of end-tidal (E) and inspired (I) gases during acute hypoxic exposures before and after chamber. (A) Control of PICO2 (prior:
circle; post: triangle) and PIO2 (prior: square; post: diamond); (B) Control of PETCO2 (prior: circle; post: triangle) and PETO2 (prior: square; post:
diamond) were averaged at 30-sec intervals during acute hypoxic exposures before and after the chamber exposure. Data from hyperoxia and
euoxia (control) protocols are shown as filled and empty symbols, respectively. The black bar shows the period of isocapnic hypoxia. Values are
means  SEM.
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reduction in acclimatization in humans, healthy Tibetans
living at sea level display a smaller degree of pulmonary
vascular acclimatization to hypoxia than Han Chinese
controls, and this is associated with a hyporesponsive
HIF-2 transcriptional system (Petousi et al. 2014).
In mice, Hodson and colleagues have recently shown
that inducible inactivation of HIF-2a, but not HIF-1a,
strikingly reduced ventilatory acclimatization to hypoxia
and associated carotid body cell proliferation (Hodson
et al. 2016). For pulmonary vascular acclimatization to
hypoxia to occur in mice, Kapitsinou et al. (2016) have
shown that it is the HIF-2a localized to the endothelium
that appears to be required, and that the linked expres-
sion of the vasoconstrictor peptide endothelin-1 may pro-
vide the mechanism of vascular smooth muscle
constriction.
Figure 5. Changes in cardiopulmonary responses during acute hypoxic exposure before and after the chamber exposure. (A) Systolic
pulmonary artery pressure (SPAP); (B) Cardiac output; (C) Stroke volume; (D) Heart rate; (E) Oxyhemoglobin saturation (SpO2). Data from
hyperoxia (filled symbols) and euoxia (control, empty symbols) protocols are labeled by symbol filling; data from prior to (circles) and post
(triangles) 8-h exposures are labeled by symbol shape. The black bar shows the period of isocapnic hypoxia. Values are means  SEM.
*P < 0.05 when comparing prior to (97.9  0.3%) and post (98.9  0.3%) hyperoxia exposures.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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These studies raise the question of whether the differ-
ing effects of oxygen on ventilatory and pulmonary vascu-
lar control reflect tissue-specific differences in cellular
HIF regulation.
Clinical implications of exposure to
hyperoxia
The nature of responses to hyperoxia also carries a
clinical relevance. Patients in hospital, divers, and pro-
fessionals in the aerospace environment are often
exposed to sustained periods of hyperoxia, and some
evidence is accruing that this may lead to harmful
physiological responses. This evidence has tended to be
of two kinds. First, physiological changes have been
observed during hyperoxia that are presumed to be
potentially harmful to tissues and organs, such as
reductions in regional blood flow and reductions in
cardiac output (Rousseau et al. 2005; Orbegozo Cortes
et al. 2015; Spoelstra-de Man et al. 2015). Second, some
studies on patient populations have demonstrated
higher morbidity or mortality in groups experiencing
higher levels of arterial oxygenation (Rincon et al. 2014;
Helmerhorst et al. 2015, 2017; Girardis et al. 2016;
Asfar et al. 2017).
Several studies have observed a decrease in cardiac
output during hyperoxia, in contrast to the absence of a
change observed here (Harten et al. 2003; Waring et al.
2003; Spoelstra-de Man et al. 2015). Changes in PETCO2
are to be anticipated during hyperoxia as ventilation
changes (Dripps and Comroe 1947; Becker et al. 1996)
and have been confirmed during hyperoxia in associa-
tion with hypocapnia (Van De Water et al. 1970; Rous-
seau et al. 2005; Weaver et al. 2009). (The current view
of why ventilation acutely rises during hyperoxia is that
the reduction in the Haldane effect renders the venous
cerebral blood acidic and this stimulates central
chemoreceptors.) Furthermore, isolated lowering of
PETCO2 itself leads to a fall in cardiac output (Balanos
et al. 2003). It thus usually remains unclear to what
extent the physiological circulatory changes seen during
hyperoxia can be attributed to changes in PCO2 in blood
rather than oxygen levels themselves. Similar considera-
tions apply to measurements of pulmonary artery pres-
sure during poikilocapnic hyperoxia (Van De Water
et al. 1970; Weaver et al. 2009). The present study
found no evidence of a fall in cardiac output with iso-
capnic hyperoxia held at a level of PETO2 of 420 mmHg
for 8 h.
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